Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study

OBJECTIVE: Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes. RESEARCH...

Descripción completa

Detalles Bibliográficos
Autores principales: Feinkohl, Insa, Keller, Marketa, Robertson, Christine M., Morling, Joanne R., Williamson, Rachel M., Nee, Lisa D., McLachlan, Stela, Sattar, Naveed, Welsh, Paul, Reynolds, Rebecca M., Russ, Tom C., Deary, Ian J., Strachan, Mark W.J., Price, Jackie F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747922/
https://www.ncbi.nlm.nih.gov/pubmed/23579182
http://dx.doi.org/10.2337/dc12-2241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747922/
https://www.ncbi.nlm.nih.gov/pubmed/23579182
http://dx.doi.org/10.2337/dc12-2241

Ejemplares similares